Pharming Reports on Financial Results for the First Half of 2019
Financial updatesPharming Group N.V. presents its (unaudited) interim financial report for the first half year ended 30 June 2019.
Pharming Group: Halfjaarcijfers 2019
Financial updatesPharming Webinar: halfjaarcijfers 2019 donderdag 25 juli 2019 tussen 19.00 en 20.00 uur. Nu aanmelden!
Pharming Reports on Annual General Meeting of Shareholders
Financial updatesPharming Group N.V. announces that at its Annual General Meeting of shareholders (AGM), held today, all proposals were approved. The presentation slides from today’s AGM are available on the Company’s website.
Pharming Group reports interim financial results for the first quarter of 2019
Financial updatesPharming Group N.V. presents its (unaudited) interim financial report for the first quarter ended 31 March 2019.
Pharming Group announces Notice to Convene to Annual General Meeting of Shareholders
Financial updatesPharming Group N.V. announces that the Notice to Convene for its Annual General Meeting of Shareholders has been uploaded on its website. Pharming’s upcoming Annual General Meeting will be held at the Holiday Inn (Haagse Schouwweg 10, 2332 KG Leiden, The Netherlands) on 22 May 2019 at 14:00 CEST.
Pharming Group announces completion of minority investment in BioConnection BV
Financial updatesPharming Group N.V. announces that following the Company’s announcement on 29 March 2019, it has completed its investment of €1.6 million in cash and conversion of €2.5 million of prepayments into new equity in its Fill & Finish partner BioConnection BV, which manufactures the sterile sealed vials of Pharming’s product RUCONEST® from the purified drug substance.
Pharming Group announces publication of its Annual Report 2018 and a provisional commitment to invest in supplier
Financial updatesPharming Group N.V. announces publication of its Annual Report for the financial year ended 31 December 2018. The Company also announces that it has made a provisional commitment to invest up to €1.6 million in cash and convert €2.5 million of prepayments into equity in its fill & finish partner BioConnection BV, which manufactures the final sealed vials of Pharming’s product RUCONEST® from the purified drug substance.
Pharming Group Reports Strong Preliminary Financial Results for 2018 including first year of net profit
Financial updatesPharming Group N.V. presents its preliminary (unaudited) financial report for the full year ended 31 December 2018.
Pharming Group: Jaarcijfers 2018
Financial updatesPharming Webinar: Jaarcijfers 2018 donderdag 7 maart 2019 tussen 19.00 en 20.00 uur. Nu aanmelden!
Pharming Group reports interim financial results for the first nine months of 2018
Financial updatesPharming Group N.V. presents its (unaudited) interim financial report for the first nine months and the third quarter ended 30 September 2018.